Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas.

Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas.

Item

http://www.wikidata.org/entity/Q37123435

Q37123435

about

Synergistic anti-tumor effects of combination of photodynamic therapy and arsenic compound in cervical cancer cells: in vivo and in vitro studies Increased ceramide accumulation correlates with downregulation of the autophagy protein ATG-7 in MCF-7 cells sensitized to photodamage.Targeting of T/Tn antigens with a plant lectin to kill human leukemia cells by photochemotherapy.Amplification of cancer cell apoptosis in photodynamic therapy-treated tumors by adjuvant ceramide analog LCL29.Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide.C16-Ceramide Analog Combined with Pc 4 Photodynamic Therapy Evokes Enhanced Total Ceramide Accumulation, Promotion of DEVDase Activation in the Absence of Apoptosis, and Augmented Overall Cell Killing C22:0- and C24:0-dihydroceramides confer mixed cytotoxicity in T-cell acute lymphoblastic leukemia cell lines.Combining anticancer agents photodynamic therapy and LCL85 leads to distinct changes in the sphingolipid profile, autophagy, caspase-3 activation in the absence of cell death, and long-term sensitization Photodynamic therapy of cancer: an update Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate Cationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors.Therapeutic applications of bioactive sphingolipids in hematological malignancies.Jaspine B induces nonapoptotic cell death in gastric cancer cells independently of its inhibition of ceramide synthase.Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.Oxovanadium(IV) complexes of curcumin for cellular imaging and mitochondria targeted photocytotoxicity.Multilayer photodynamic therapy for highly effective and safe cancer treatment.

P2860

Q28484167-4E53E5CF-9FBA-4D7D-9C58-792BDCF2640E Q33880530-47AD30DB-8107-4693-9CAF-9872ADE56168 Q33999425-938A5235-EE64-438E-8BD1-E756CA85E5B4 Q34068154-81C1BD9B-ABF9-4166-8325-39BA1EBE75FB Q34182665-81BCF81E-294A-449E-B8F9-F80C5C8CF8A7 Q34736432-04246A36-AD6A-4709-9172-D79720D3EF7B Q34990343-27676F25-50E1-4612-809D-DCAF297D661B Q35069168-F210780E-AAF5-46AE-B0D4-5B5E809D2C12 Q35532394-6062170D-18E0-4628-BBF3-4551E33E06D0 Q35952297-22869F05-86C4-4404-AAE0-A0EC848FDE0F Q36326049-AA228FA9-96B2-41B1-AC8D-EB1DD9B561F0 Q37131905-1B89D255-1083-4EAC-B9A3-07D66D06C7C5 Q37163553-312528D9-8CC7-472C-8E48-1CE4FFFC1509 Q37760875-E3B14951-4D3D-46C0-AAB5-62A2889E250E Q38701564-68E5F213-B103-4FDC-B518-363082ACA46B Q38831997-C1DBC9EF-CB01-4A91-AE25-A496292A99C2 Q46860046-272EE1E0-E464-4083-8E03-117D929E5A4B Q50675905-2DB451D7-55F7-4E96-A59A-71D672B255EF

P2860

Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas.

Item

http://www.wikidata.org/entity/Q37123435

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs